Page 526 - Hematology_ Basic Principles and Practice ( PDFDrive )

444.e2 Part IV Disorders of Hematopoietic Cell Development

transplantation for acquired aplastic anemia. Bone Marrow Transplant 76. Lima CS, Paula EV, Takahashi T, et al: Causes of incidental neutropenia
30:405, 2002. in adulthood. Ann Hematol 85:705, 2006.
49. Gmur JP, Burger J, Schaffner A, et al: Pure red cell aplasia of long 77. Chandra Sekhar C, Ramana Reddi V, Srinivas B, et al: Pure red cell
duration complicating major ABO-incompatible bone marrow trans- aplasia associated with carbamazepine. J Assoc Physicians India 46:655,
plantation. Blood 75:290, 1990. 1998.
50. Grigg AP, Juneja SK: Pure red cell aplasia with the onset of graft versus 78. MacCulloch D, Jackson JM, Venerys J: Letter: Drug-induced red cell
host disease. Bone Marrow Transplant 32:1099, 2003. aplasia. Br Med J 4:163, 1974.
51. Choudry MA, Moffett BK, Laber DA: Pure red-cell aplasia secondary 79. Fernandez de Sevilla T, Alegre J, Vallespi T, et al: Adult pure red cell
to pregnancy, characterization of a syndrome. Ann Hematol 86:233, aplasia following topical ocular chloramphenicol. Br J Ophthalmol
2007. 74:640, 1990.
52. Bambery P, Varma N, Varma S, et al: Prolonged, pregnancy-related pure 80. Gill MJ, Ratliff DA, Harding LK: Hypoglycemic coma, jaundice, and
red cell aplasia; a case report. Eur J Obstet Gynecol Reprod Biol 42:233, pure RBC aplasia following chlorpropamide therapy. Arch Intern Med
1991. 140:714, 1980.
53. Dan K, Ito T, Nomura T: Pure red cell aplasia following pernicious 81. Planas AT, Kranwinkel RN, Soletsky HB, et al: Chlorpropamide-
anemia. Am J Hematol 33:148, 1990. induced pure RBC aplasia. Arch Intern Med 140:707, 1980.
54. Foy H, Kondi A, Macdougall L: Pure red-cell aplasia in marasmus and 82. Chasty RC, Myint H, Oscier DG, et al: Autoimmune haemolysis in
kwashiorkor treated with riboflavine. Br Med J 1:937, 1961. patients with B-CLL treated with chlorodeoxyadenosine (CDA). Leuk
55. Pasternack A, Wahlberg P: Bone marrow in acute renal failure. Acta Lymphoma 29:391, 1998.
Med Scand 181:505, 1967. 83. Unter CE, Abbott GD: Co-trimoxazole red cell aplasia in leukaemia.
56. Matsuhashi Y, Tasaka T, Uehara E, et al: Increased expression of c-maf Arch Dis Child 62:85, 1987.
in pure red cell aplasia secondary to plasma cell dyscrasia. Leuk Lym- 84. Tishler M, Kahn Y, Yaron M: Pure red cell aplasia caused by
phoma 44:523, 2003. D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis
57. Fujisao S, Tsuda H: Th1/Th2 balance alteration in the clinical course 50:255, 1991.
of a patient with pure red cell aplasia and thymoma. Br J Haematol 85. Boorman GA, Luster MI, Dean JH, et al: Assessment of myelotoxicity
103:308, 1998. caused by environmental chemicals. Environ Health Perspect 43:129,
58. Chung JW, Suh YJ, Song HJ, et al: Pure red cell aplasia and adult-onset 1982.
Still’s disease. Clin Rheumatol 23:368, 2004. 86. Borthakur G, O’Brien S, Wierda WG, et al: Immune anaemias in
59. Janssen HL, van Laar JM, van Hoek B, et al: Severe hepatitis and pure patients with chronic lymphocytic leukaemia treated with fludarabine,
red cell aplasia in adult Still’s disease: Good response to immunosup- cyclophosphamide and rituximab—incidence and predictors. Br J
pressive therapy. Dig Dis Sci 44:1639, 1999. Haematol 136:800, 2007.
60. Fong PH, Wee A, Chan HL, et al: Primary thymic carcinoma and 87. Suzuki S, Osaka Y, Nakai I, et al: Pure red cell aplasia induced by
its association with dermatomyositis and pure red cell aplasia. Int J FK506. Transplantation 61:831, 1996.
Dermatol 31:426, 1992. 88. Hansen RM, Varma RR, Hanson GA: Gold induced hepatitis and
61. Katabami S, Sugiyama T, Kodama T, et al: Polymyositis associated with pure red cell aplasia. Complete recovery after corticosteroid and
thymoma and the subsequent development of pure red cell aplasia. N-acetylcysteine therapy. J Rheumatol 18:1251, 1991.
Intern Med 34:569, 1995. 89. Jurgensen JC, Abraham JP, Hardy WW: Erythroid aplasia after halo-
62. Rodrigues JF, Harth M, Barr RM: Pure red cell aplasia in rheumatoid thane hepatitis. Report of a case. Am J Dig Dis 15:577, 1970.
arthritis. J Rheumatol 15:1159, 1988. 90. Sacchi S, Gugliotta L, Papineschi F, et al: Alfa-interferon in the treat-
63. Fujiu K, Kanno R, Shio Y, et al: Triad of thymoma, myasthenia gravis ment of essential thrombocythemia: Clinical results and evaluation
and pure red cell aplasia combined with Sjögren’s syndrome. Jpn J of its biological effects on the hematopoietic neoplastic clone. Italian
Thorac Cardiovasc Surg 52:345, 2004. Cooperative Group on ET. Leukemia 12:289, 1998.
64. Arcasoy MO, Chao NJ: T-cell-mediated pure red-cell aplasia in systemic 91. Mazur EM, Rosmarin AG, Sohl PA, et al: Analysis of the mechanism of
lupus erythematosus: Response to cyclosporin A and mycophenolate anagrelide-induced thrombocytopenia in humans. Blood 79:1931, 1992.
mofetil. Am J Hematol 78:161, 2005. 92. Marseglia GL, Locatelli F: Isoniazid-induced pure red cell aplasia in two
65. Meyer RJ, Hoffman R, Zanjani ED: Autoimmune hemolytic anemia siblings. J Pediatr 132:898, 1998.
and periodic pure red cell aplasia in systemic lupus erythematosus. Am 93. Veale KS, Huff ES, Nelson BK, et al: Pure red cell aplasia and hepatitis
J Med 65:342, 1978. in a child receiving isoniazid therapy. J Pediatr 120:146, 1992.
66. Bailey FA, Lilly M, Bertoli LF, et al: An antibody that inhibits in vitro 94. Hoffman R, McPhedran P, Benz EJ, Jr, et al: Isoniazid-induced pure
bone marrow proliferation in a patient with systemic lupus erythema- red cell aplasia. Am J Med Sci 286:2, 1983.
tosus and aplastic anemia. Arthritis Rheum 32:901, 1989. 95. Majluf-Cruz A, Luna-Castanos G, Trevino-Perez S, et al: Lamivudine-
67. Linardaki GD, Boki KA, Fertakis A, et al: Pure red cell aplasia as presen- induced pure red cell aplasia. Am J Hematol 65:189, 2000.
tation of systemic lupus erythematosus: Antibodies to erythropoietin. 96. Monson T, Schichman SA, Zent CS: Linezolid-induced pure red blood
Scand J Rheumatol 28:189, 1999. cell aplasia. Clin Infect Dis 35:E29, 2002.
68. Dessypris EN, Redline S, Harris JW, et al: Diphenylhydantoin-induced 97. Nicholls MD, Concannon AJ: Maloprim-induced agranulocytosis and
pure red cell aplasia. Blood 65:789, 1985. red-cell aplasia. Med J Aust 2:564, 1982.
69. Thachil J, Salim R: Campath-1H induced pure red cell aplasia in a 98. Hodo Y, Tsuji K, Mizukoshi E, et al: Pure red cell aplasia associated
patient with chronic lymphatic leukaemia. Leuk Res 31:1025, 2006. with concomitant use of mycophenolate mofetil and ribavirin in post-
70. Shankar P, Aish L, Hassoun H: Allopurinol-induced pure red cell transplant recurrent hepatitis C. Transpl Int 19:170, 2006.
aplasia. Am J Hematol 73:69, 2003. 99. Cavanzo FJ, Garcia CF, Botero RC: Chronic cholestasis, paucity of
71. Lin YW, Okazaki S, Hamahata K, et al: Acute pure red cell aplasia bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An
associated with allopurinol therapy. Am J Hematol 61:209, 1999. ampicillin-associated case. Gastroenterology 99:854, 1990.
72. Itoh K, Wong P, Asai T, et al: Pure red cell aplasia induced by alpha- 100. Giorgino R: Hemorrhagic syndrome with medullary aplasia of notable
methyldopa. Am J Med 84:1088, 1988. gravity during mixed therapy with phenylbutazone and Pyramidon.
73. Blanchet E, Beau P, Frat JP: Bone marrow aplasia following dipyrone Progr Med (Napoli) 19:316, 1963.
treatment in a patient with Crohn’s disease receiving long-term metho- 101. Kueh YK, Yeo TC, Choo MH: Reversible pure red cell aplasia associ-
trexate. Gastroenterol Clin Biol 28:502, 2004. ated with diphenylhydantoin therapy. Ann Acad Med Singapore 20:407,
74. Agrawal A, Parrott NR, Riad HN, et al: Azathioprine-induced pure red 1991.
cell aplasia: Case report and review. Transplant Proc 36:2689, 2004. 102. Huijgens PC, Thijs LG, den Ottolander GJ: Pure red cell aplasia, toxic
75. Pruijt JF, Haanen JB, Hollander AA, et al: Azathioprine-induced pure dermatitis and lymphadenopathy in a patient taking diphenylhydan-
red-cell aplasia. Nephrol Dial Transplant 11:1371, 1996. toin. Acta Haematol 59:31, 1978.